Ryan D. Maynard, EVP & CFO at RIGEL PHARMACEUTICALS INC (RIGL), sold 1,700 shares at $10.61 ($18K) on 2012-08-07, disclosed to the SEC on 2012-08-09.
Open-market sale of $18k RIGL by EVP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.60 | 700 | $7K | 41.1% |
| 2 | $10.61 | 100 | $1K | 5.9% |
| 3 | $10.62 | 600 | $6K | 35.3% |
| 4 | $10.63 | 300 | $3K | 17.7% |
| Total | $10.61 avg | 1,700 | $18K | 100% |
| Filing → |
| IOVA | BUY | 2022-06-02 | $51K | — | Filing → |
| RIGL | SELL | 2017-11-07 | $390K | — | Filing → |
| RIGL | SELL | 2012-09-14 | $249K | — | Filing → |